English, PDF, 325kb
There are 37 faculties of medicine in Germany offering medical education, including a private university. Admission to medical studies remains highly competitive. In 2011, 37,400 students applied but only 9,432 students were admitted (roughly one out of four).
English, PDF, 301kb
In Germany, there are two main categories of nurses, first level and second level. A majority of first level nurses are trained through a 3-year vocational training programme involving hospital-based training, and these nurses can go on to pursue further education and training to specialise within the hospital setting.
Specific country notes have been prepared using data from the database OECD Health Statistics 2015, July 2015 version. The notes are available in PDF format.
English, PDF, 236kb
Progress has been made to reduce smoking rates and alcohol consumption in Germany, but obesity is on the rise as in most other EU countries. As in other EU countries, spending for prevention in Germany accounts only for around 3% of current health spending.
The global economic crisis has had a profound impact on people’s well-being, reaching far beyond the loss of jobs and income, and affecting citizens’ satisfaction with their lives and their trust in governments, according to a new OECD report.
To help inform the Conference on Managing Hospital Volumes, co-organised by the German Federal Ministry of Health and the OECD, and held on the 11th April 2013 in Berlin, the OECD Secretariat produced a paper to provide an international perspective on Germany’s situation and the current policy debate.
Across OECD countries some 83 million people suffer from diabetes. On current trends, that will rise to almost 100 million by 2030.
To assess the feasibility of using secondary data sets information to feed an output-based PPP approach for hospital services, we reviewed the main characteristics of diagnoses and procedures coding standards, DRG classification systems, and cost-finding methods used in selected OECD countries.
The mortality amenable to health care is defined as a possible indicator to measure the health care systems performance in preventing premature deaths that can be avoided by appropriate health care intervention. This paper assesses the feasibility of using this indicator in OECD countries.
For many of today’s new biomedical innovations, the distinctions between different forms of medical products such as drugs, diagnostics and devices no longer apply. Biomedicine also tends to realize its potential today through process innovation, even more than product innovation.